115 related articles for article (PubMed ID: 7492253)
1. Altered glutamatergic and GABAergic mechanisms in the cingulate cortex of the schizophrenic brain.
Benes FM
Arch Gen Psychiatry; 1995 Dec; 52(12):1015-8; discussion 1019-24. PubMed ID: 7492253
[No Abstract] [Full Text] [Related]
2. Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder.
Woo TU; Walsh JP; Benes FM
Arch Gen Psychiatry; 2004 Jul; 61(7):649-57. PubMed ID: 15237077
[TBL] [Abstract][Full Text] [Related]
3. Reduced [3H]flunitrazepam binding in cingulate cortex and hippocampus of postmortem schizophrenic brains: is selective loss of glutamatergic neurons associated with major psychoses?
Squires RF; Lajtha A; Saederup E; Palkovits M
Neurochem Res; 1993 Feb; 18(2):219-23. PubMed ID: 8097289
[TBL] [Abstract][Full Text] [Related]
4. Selective alterations in ionotropic glutamate receptors in the anterior cingulate cortex in schizophrenia.
Zavitsanou K; Ward PB; Huang XF
Neuropsychopharmacology; 2002 Nov; 27(5):826-33. PubMed ID: 12431856
[TBL] [Abstract][Full Text] [Related]
5. Receptor architecture of human cingulate cortex: evaluation of the four-region neurobiological model.
Palomero-Gallagher N; Vogt BA; Schleicher A; Mayberg HS; Zilles K
Hum Brain Mapp; 2009 Aug; 30(8):2336-55. PubMed ID: 19034899
[TBL] [Abstract][Full Text] [Related]
6. Amyloid β causes excitation/inhibition imbalance through dopamine receptor 1-dependent disruption of fast-spiking GABAergic input in anterior cingulate cortex.
Ren SQ; Yao W; Yan JZ; Jin C; Yin JJ; Yuan J; Yu S; Cheng Z
Sci Rep; 2018 Jan; 8(1):302. PubMed ID: 29321592
[TBL] [Abstract][Full Text] [Related]
7. Sex differences in GABAergic gene expression occur in the anterior cingulate cortex in schizophrenia.
Bristow GC; Bostrom JA; Haroutunian V; Sodhi MS
Schizophr Res; 2015 Sep; 167(1-3):57-63. PubMed ID: 25660468
[TBL] [Abstract][Full Text] [Related]
8. Glutamate transporter splice variant expression in an enriched pyramidal cell population in schizophrenia.
O'Donovan SM; Hasselfeld K; Bauer D; Simmons M; Roussos P; Haroutunian V; Meador-Woodruff JH; McCullumsmith RE
Transl Psychiatry; 2015 Jun; 5(6):e579. PubMed ID: 26057049
[TBL] [Abstract][Full Text] [Related]
9. D2 and D4 dopamine receptor mRNA distribution in pyramidal neurons and GABAergic subpopulations in monkey prefrontal cortex: implications for schizophrenia treatment.
de Almeida J; Mengod G
Neuroscience; 2010 Nov; 170(4):1133-9. PubMed ID: 20727949
[TBL] [Abstract][Full Text] [Related]
10. Alterations of muscarinic and GABA receptor binding in the posterior cingulate cortex in schizophrenia.
Newell KA; Zavitsanou K; Jew SK; Huang XF
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):225-33. PubMed ID: 16901598
[TBL] [Abstract][Full Text] [Related]
11. Glutamate receptor dysfunction and schizophrenia.
Olney JW; Farber NB
Arch Gen Psychiatry; 1995 Dec; 52(12):998-1007. PubMed ID: 7492260
[TBL] [Abstract][Full Text] [Related]
12. Comparison of glutamate and gamma-aminobutyric acid uptake binding sites in frontal and temporal lobes in schizophrenia.
Simpson MD; Slater P; Deakin JF
Biol Psychiatry; 1998 Sep; 44(6):423-7. PubMed ID: 9777172
[TBL] [Abstract][Full Text] [Related]
13. Loss of dopamine D2 receptors increases parvalbumin-positive interneurons in the anterior cingulate cortex.
Graham DL; Durai HH; Garden JD; Cohen EL; Echevarria FD; Stanwood GD
ACS Chem Neurosci; 2015 Feb; 6(2):297-305. PubMed ID: 25393953
[TBL] [Abstract][Full Text] [Related]
14. Synaptic dysfunction in schizophrenia.
Yin DM; Chen YJ; Sathyamurthy A; Xiong WC; Mei L
Adv Exp Med Biol; 2012; 970():493-516. PubMed ID: 22351070
[TBL] [Abstract][Full Text] [Related]
15. Model generation and testing to probe neural circuitry in the cingulate cortex of postmortem schizophrenic brain.
Benes FM
Schizophr Bull; 1998; 24(2):219-30. PubMed ID: 9613622
[TBL] [Abstract][Full Text] [Related]
16. Signal transmission, rather than reception, is the underlying neurochemical abnormality in schizophrenia.
Dean B
Aust N Z J Psychiatry; 2000 Aug; 34(4):560-9. PubMed ID: 10954386
[TBL] [Abstract][Full Text] [Related]
17. Dopaminergic modulation of impaired cognitive activation in the anterior cingulate cortex in schizophrenia.
Dolan RJ; Fletcher P; Frith CD; Friston KJ; Frackowiak RS; Grasby PM
Nature; 1995 Nov; 378(6553):180-2. PubMed ID: 7477319
[TBL] [Abstract][Full Text] [Related]
18. Neuronal calcium-binding proteins and schizophrenia.
Eyles DW; McGrath JJ; Reynolds GP
Schizophr Res; 2002 Sep; 57(1):27-34. PubMed ID: 12165373
[TBL] [Abstract][Full Text] [Related]
19. Exogenous dopamine reduces GABA receptor availability in the human brain.
Lou HC; Rosenstand A; Brooks DJ; Bender D; Jakobsen S; Blicher JU; Hansen KV; Møller A
Brain Behav; 2016 Jul; 6(7):e00484. PubMed ID: 27247854
[TBL] [Abstract][Full Text] [Related]
20. Regulation of intermittent oscillatory activity of pyramidal cell neurons by GABA inhibitory interneurons is impaired in schizophrenia: rationale for pharmacotherapeutic GABAergic interventions.
Deutsch SI; Rosse RB; Schwartz BL; Mastropaolo J; Burket JA; Weizman A
Isr J Psychiatry Relat Sci; 2010; 47(1):17-26. PubMed ID: 20686196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
